z-logo
open-access-imgOpen Access
Letter by Cheen Regarding Article, “Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States”
Author(s) -
McVin Hua Heng Cheen
Publication year - 2019
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.118.038646
Subject(s) - apixaban , medicine , atrial fibrillation , kidney disease , intensive care medicine , stroke (engine) , end stage renal disease , randomized controlled trial , cardiology , disease , warfarin , rivaroxaban , mechanical engineering , engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom